-
2
-
-
77954637445
-
Genetically engineered mouse models in cancer research [J]
-
Walrath JC, Hawes JJ, Van Dyke T, et al. Genetically engineered mouse models in cancer research [J]. Adv Cancer Res, 2010,106:113-164.
-
(2010)
Adv Cancer Res
, vol.106
, pp. 113-164
-
-
Walrath, J.C.1
Hawes, J.J.2
van Dyke, T.3
-
3
-
-
0022380768
-
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice [J]
-
Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice [J]. Nature, 1985,318 (6046): 533-538.
-
(1985)
Nature
, vol.318
, Issue.6046
, pp. 533-538
-
-
Adams, J.M.1
Harris, A.W.2
Pinkert, C.A.3
-
4
-
-
0021720781
-
Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes [J]
-
Stewart TA, Pattengale PK, Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes [J]. Cell, 1984,38(3):627-637.
-
(1984)
Cell
, vol.38
, Issue.3
, pp. 627-637
-
-
Stewart, T.A.1
Pattengale, P.K.2
Leder, P.3
-
5
-
-
0026561121
-
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours [J]
-
Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours [J]. Nature, 1992,356(6366):215-221.
-
(1992)
Nature
, vol.356
, Issue.6366
, pp. 215-221
-
-
Donehower, L.A.1
Harvey, M.2
Slagle, B.L.3
-
6
-
-
0026702996
-
Effects of an Rb mutation in the mouse [J]
-
Jacks T, Fazeli A, Schmitt EM, et al. Effects of an Rb mutation in the mouse [J]. Nature, 1992,359(6393):295-300.
-
(1992)
Nature
, vol.359
, Issue.6393
, pp. 295-300
-
-
Jacks, T.1
Fazeli, A.2
Schmitt, E.M.3
-
7
-
-
0037022606
-
Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function [J]
-
De Vries A, Flores ER, Miranda B, et al. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function [J]. Proc Natl Acad Sci U S A, 2002,99(5): 2948-2953.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.5
, pp. 2948-2953
-
-
de Vries, A.1
Flores, E.R.2
Miranda, B.3
-
8
-
-
0023046599
-
The role of the loxP spacer region in P1 site-specific recombination [J]
-
Hoess RH, Wierzbicki A, Abremski K. The role of the loxP spacer region in P1 site-specific recombination [J]. Nucleic Acids Res, 1986,14(5):2287-2300.
-
(1986)
Nucleic Acids Res
, vol.14
, Issue.5
, pp. 2287-2300
-
-
Hoess, R.H.1
Wierzbicki, A.2
Abremski, K.3
-
9
-
-
70450200747
-
New approaches for modelling sporadic genetic disease in the mouse [J]
-
Fisher EM, Lana-Elola E, Watson SD, et al. New approaches for modelling sporadic genetic disease in the mouse [J]. Dis Model Mech, 2009,2(9-10):446-453.
-
(2009)
Dis Model Mech
, vol.2
, Issue.9-10
, pp. 446-453
-
-
Fisher, E.M.1
Lana-Elola, E.2
Watson, S.D.3
-
10
-
-
34347344980
-
Tissue-specific and reversible RNA interference in transgenic mice [J]
-
Dickins RA, McJunkin K, Hernando E, et al. Tissue-specific and reversible RNA interference in transgenic mice [J]. Nat Genet, 2007,39(7):914-921.
-
(2007)
Nat Genet
, vol.39
, Issue.7
, pp. 914-921
-
-
Dickins, R.A.1
McJunkin, K.2
Hernando, E.3
-
11
-
-
0035490099
-
Engineering chromosomal rearrangements in mice [J]
-
Yu Y, Bradley A. Engineering chromosomal rearrangements in mice [J]. Nat Rev Genet, 2001,2(10):780-790.
-
(2001)
Nat Rev Genet
, vol.2
, Issue.10
, pp. 780-790
-
-
Yu, Y.1
Bradley, A.2
-
12
-
-
0032477721
-
Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice [J]
-
Holland EC, Varmus HE. Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice [J]. Proc Natl Acad Sci U S A, 1998,95(3):1218-1223.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, Issue.3
, pp. 1218-1223
-
-
Holland, E.C.1
Varmus, H.E.2
-
13
-
-
77956651594
-
Modeling metastasis in the mouse [J]
-
Bos PD, Nguyen DX, Massague J. Modeling metastasis in the mouse [J]. Curr Opin Pharmacol, 2010,10(5):571-577.
-
(2010)
Curr Opin Pharmacol
, vol.10
, Issue.5
, pp. 571-577
-
-
Bos, P.D.1
Nguyen, D.X.2
Massague, J.3
-
14
-
-
79952113235
-
Cachexia in cancer: Is it treatable at the molecular level? [J]
-
Vanchieri C. Cachexia in cancer: is it treatable at the molecular level? [J]. J Natl Cancer Inst, 2010,102(22):1694-1697.
-
(2010)
J Natl Cancer Inst
, vol.102
, Issue.22
, pp. 1694-1697
-
-
Vanchieri, C.1
|